Generic recorded 16.7% share of the domestic chemotherapy market

Published: 2014-05-12 14:44:01

Updated: 2014-05-12 14:44:01

On May 8 according to the pharmaceutical industry, in domestic chemotherapy market, generic recorded 16.7% share of the market (IMS sales audit criteria). Based on the data, there have none of 100 million blockbuster items.

Only colorectal cancer • stomach cancer treatment Eloxatin Injection (Sanofi • oxaliplatin) generic is in the upper ranks and replaced the original. Oxapla, Oxalitin from B...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.